HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 89 filers reported holding HARPOON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $9,406,000 | -54.8% | 1,190,600 | -20.6% | 0.21% | -63.0% |
| Q2 2021 | $20,805,000 | -29.4% | 1,500,000 | +6.5% | 0.56% | -31.0% |
| Q1 2021 | $29,455,000 | +125.9% | 1,408,000 | +79.4% | 0.81% | +92.4% |
| Q4 2020 | $13,039,000 | -34.5% | 785,000 | -33.0% | 0.42% | -54.2% |
| Q3 2020 | $19,907,000 | -0.6% | 1,171,700 | -2.9% | 0.92% | -28.1% |
| Q2 2020 | $20,025,000 | – | 1,206,351 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |